nach oben

Neurological Sciences

Erschienen in:

Open Access 12.02.2020 | Review Article

Research on cognitive and sociocognitive functions in patients with brain tumours: a bibliometric analysis and visualization of the scientific landscape

verfasst von: Milena Pertz, Stoyan Popkirov, Uwe Schlegel, Patrizia Thoma

Erschienen in: Neurological Sciences | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Many patients with brain tumours exhibit mild to severe (neuro)cognitive impairments at some point during the course of the disease. Social cognition, as an instance of higher-order cognitive functioning, specifically enables initiation and maintenance of appropriate social interactions. For individuals being confronted with the diagnosis of a brain tumour, impairment of social function represents an additional burden, since those patients deeply depend on support and empathy provided by family, friends and caregivers.

Methods

The present study explores the scientific landscape on (socio)cognitive functioning in brain tumour patients by conducting a comprehensive bibliometric analysis using VOSviewer. The Web of Science Core Collection database was examined to identify relevant documents published between 1945 and 2019.

Results

A total of 664 English titles on (socio)cognitive functions in patients with brain tumours was retrieved. Automated textual analysis revealed that the data available so far focus on three major topics in brain tumour patients: cognitive functions in general and in paediatric cases, as well as psychological factors and their influence on quality of life. The focus of research has gradually moved from clinical studies with cognitive functions as one of the outcome measures to investigations of interactions between cognitive functions and psychological constructs such as anxiety, depression or fatigue. Medical, neurological and neuropsychological journals, in particular neuro-oncological journals published most of the relevant articles authored by a relatively small network of well interconnected researchers in the field.

Conclusion

The bibliometric analysis highlights the necessity of more research on social cognition in brain tumour patients.

Aaronson NK, Taphoorn MJB, Heimans JJ, Postma TJ, Gundy CM, Beute GN, Slotman BJ, Klein M (2011) Compromised health-related quality of life in patients with low-grade glioma. J Clin Oncol 29(33):4430–4435. https://doi.org/10.1200/JCO.2011.35.5750 CrossRefPubMed

Bunevicius A, Tamasauskas S, Deltuva VP, Tamasauskas A, Radziunas A, Bunevicius R (2014) Predictors of health-related quality of life in neurosurgical brain tumor patients: focus on patient-centered perspective. Acta Neurochir 156(2):367–374. https://doi.org/10.1007/s00701-013-1930-7 CrossRefPubMed

Hahn CA, Dunn RH, Logue PE et al (2003) Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys 55(4):992–999CrossRefPubMed

Scheibel RS, Meyers CA, Levin VA (1996) Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment. J Neuro-Oncol 30(1):61–69CrossRef

Weitzner MA, Meyers CA, Byrne K (1996) Psychosocial functioning and quality of life in patients with primary brain tumors. J Neurosurg 84(1):29–34. https://doi.org/10.3171/jns.1996.84.1.0029 CrossRefPubMed

Zucchella C, Bartolo M, Di Lorenzo C et al (2013) Cognitive impairment in primary brain tumors outpatients: a prospective cross-sectional survey. J Neuro Oncol 112(3):455–460. https://doi.org/10.1007/s11060-013-1076-8 CrossRef

Habets EJJ, Kloet A, Walchenbach R, Vecht CJ, Klein M, Taphoorn MJ (2014) Tumour and surgery effects on cognitive functioning in high-grade glioma patients. Acta Neurochir 156(8):1451–1459. https://doi.org/10.1007/s00701-014-2115-8 CrossRefPubMed

Schagen SB, Klein M, Reijneveld JC, Brain E, Deprez S, Joly F, Scherwath A, Schrauwen W, Wefel JS (2014) Monitoring and optimising cognitive function in cancer patients: present knowledge and future directions. EJC Suppl 12(1):29–40. https://doi.org/10.1016/j.ejcsup.2014.03.003 CrossRefPubMedPubMedCentral

Taphoorn MJB, Klein M (2004) Cognitive deficits in adult patients with brain tumours. Lancet Neurol 3(3):159–168. https://doi.org/10.1016/S1474-4422(04)00680-5 CrossRefPubMed

10.

Correa DD (2010) Neurocognitive function in brain tumors. Curr Neurol Neurosci Rep 10(3):232–239. https://doi.org/10.1007/s11910-010-0108-4 CrossRefPubMed

11.

Douw L, Klein M, Fagel SSAA, van den Heuvel J, Taphoorn MJ, Aaronson NK, Postma TJ, Vandertop WP, Mooij JJ, Boerman RH, Beute GN, Sluimer JD, Slotman BJ, Reijneveld JC, Heimans JJ (2009) Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol 8(9):810–818. https://doi.org/10.1016/S1474-4422(09)70204-2 CrossRefPubMed

12.

Klein M (2012) Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalities. Neuro-Oncology 14(Suppl 4):17–24. https://doi.org/10.1093/neuonc/nos161 CrossRef

13.

Adolphs R (2001) The neurobiology of social cognition. Curr Opin Neurobiol 11(2):231–239CrossRefPubMed

14.

Baron-Cohen S, Wheelwright S (2004) The empathy quotient: an investigation of adults with Asperger syndrome or high functioning autism, and normal sex differences. J Autism Dev Disord 34(2):163–175. https://doi.org/10.1023/B:JADD.0000022607.19833.00 CrossRefPubMed

15.

Lovely MP, Stewart-Amidei C, Page M, Mogensen K, Arzbaecher J, Lupica K, Maher ME (2013) A new reality: long-term survivorship with a malignant brain tumor. Oncol Nurs Forum 40(3):267–274. https://doi.org/10.1188/13.ONF.267-274 CrossRefPubMed

16.

Ownsworth T, Chambers SK, Hawkes A, Walker DG, Shum D (2011) Making sense of brain tumour: a qualitative investigation of personal and social processes of adjustment. Neuropsychol Rehabil 21(1):117–137. https://doi.org/10.1080/09602011.2010.537073 CrossRefPubMed

17.

Payne S, Jarrett N, Jeffs D, Brown L (2001) Implications of social isolation during cancer treatment. The implications of residence away from home during cancer treatment on patients’ experiences: a comparative study. Health Place 7(4):273–282CrossRefPubMed

18.

Cobb S (1976) Social support as a moderator of life stress. Psychosom Med 38(5):300–314CrossRefPubMed

19.

Hendriks EJ, Habets EJJ, Taphoorn MJB, Douw L, Zwinderman AH, Vandertop WP, Barkhof F, Klein M, de Witt Hamer PC (2018) Linking late cognitive outcome with glioma surgery location using resection cavity maps. Hum Brain Mapp 39(5):2064–2074. https://doi.org/10.1002/hbm.23986 CrossRefPubMedPubMedCentral

20.

Klein M, Taphoorn MJB, Heimans JJ, van der Ploeg H, Vandertop WP, Smit EF, Leenstra S, Tulleken CA, Boogerd W, Belderbos JS, Cleijne W, Aaronson NK (2001) Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J Clin Oncol 19(20):4037–4047. https://doi.org/10.1200/JCO.2001.19.20.4037 CrossRefPubMed

21.

Meyers CA, Brown PD (2006) Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol 24(8):1305–1309. https://doi.org/10.1200/JCO.2005.04.6086 CrossRefPubMed

22.

Tucha O, Smely C, Preier M, Lange KW (2000) Cognitive deficits before treatment among patients with brain tumors. Neurosurgery 47(2):324–333. https://doi.org/10.1097/00006123-200008000-00011 CrossRefPubMed

23.

van Eck NJ, Waltman L (2011) Text mining and visualization using VOSviewer. arXiv preprint:1–5

24.

van Eck NJ, Waltman L (2010) Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 84(2):523–538. https://doi.org/10.1007/s11192-009-0146-3 CrossRefPubMed

25.

van Eck NJ, Waltman L, Noyons ECM, Buter RK (2010) Automatic term identification for bibliometric mapping. Scientometrics 82(3):581–596. https://doi.org/10.1007/s11192-010-0173-0 CrossRefPubMedPubMedCentral

26.

van Eck NJ, Waltman L (2013) VOSviewer manual. Univeristeit Leiden, Leiden 1(1)

27.

Popkirov S, Jungilligens J, Schlegel U, Wellmer J (2018) Research on dissociative seizures: a bibliometric analysis and visualization of the scientific landscape. Epilepsy Behav 83:162–167. https://doi.org/10.1016/j.yebeh.2018.03.041 CrossRefPubMed

28.

Bigler ED (2017) Structural neuroimaging in neuropsychology: history and contemporary applications. Neuropsychology 31(8):934–953. https://doi.org/10.1037/neu0000418 CrossRefPubMed

29.

Meyers CA, Wefel JS (2003) The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. J Clin Oncol 21(19):3557–3558. https://doi.org/10.1200/JCO.2003.07.080 CrossRefPubMed

30.

Robinson GA, Biggs V, Walker DG (2015) Cognitive screening in brain tumors: short but sensitive enough? Front Oncol 5(60):1–7. https://doi.org/10.3389/fonc.2015.00060 CrossRef

31.

Kawada T (2019) Montreal Cognitive Assessment (MoCA) and its memory tasks for detecting mild cognitive impairment. Neurol Sci 40(3):633. https://doi.org/10.1007/s10072-018-3616-7 CrossRefPubMed

32.

Li X, Jia S, Zhou Z, Jin Y, Zhang X, Hou C, Zheng W, Rong P, Jiao J (2018) The role of the Montreal Cognitive Assessment (MoCA) and its memory tasks for detecting mild cognitive impairment. Neurol Sci 39(6):1029–1034. https://doi.org/10.1007/s10072-018-3319-0 CrossRefPubMed

33.

Milosevich E, Pendlebury S, Demeyere N (2019) Reply to: “Diagnostic test accuracy of the Montreal Cognitive Assessment in the detection of post-stroke cognitive impairment under different stages and cutoffs: a systematic review and meta-analysis”. Neurol Sci 40(7):1485–1486. https://doi.org/10.1007/s10072-019-03740-7 CrossRefPubMed

34.

Shi D, Chen X, Li Z (2018) Diagnostic test accuracy of the Montreal Cognitive Assessment in the detection of post-stroke cognitive impairment under different stages and cutoffs: a systematic review and meta-analysis. Neurol Sci 39(4):705–716. https://doi.org/10.1007/s10072-018-3254-0 CrossRefPubMed

35.

Arndt J, Das E, Schagen SB, Reid-Arndt SA, Cameron LD, Ahles TA (2014) Broadening the cancer and cognition landscape: the role of self-regulatory challenges. Psychooncology 23(1):1–8. https://doi.org/10.1002/pon.3351 CrossRefPubMed

36.

Arnold SD, Forman LM, Brigidi BD, Carter KE, Schweitzer HA, Quinn HE, Guill AB, Herndon JE 2nd, Raynor RH (2008) Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. Neuro-Oncology 10(2):171–181. https://doi.org/10.1215/15228517-2007-057 CrossRefPubMedPubMedCentral

37.

Noll KR, Bradshaw ME, Weinberg JS, Wefel JS (2017) Relationships between neurocognitive functioning, mood, and quality of life in patients with temporal lobe glioma. Psychooncology 26(5):617–624. https://doi.org/10.1002/pon.4046 CrossRefPubMed

38.

Richter A, Woernle CM, Krayenbühl N, Kollias S, Bellut D (2015) Affective symptoms and white matter changes in brain tumor patients. World Neurosurg 84(4):927–932. https://doi.org/10.1016/j.wneu.2015.05.031 CrossRefPubMed

39.

Boele FW, Heimans JJ, Aaronson NK, Taphoorn MJ, Postma TJ, Reijneveld JC, Klein M (2013) Health-related quality of life of significant others of patients with malignant CNS versus non-CNS tumors: a comparative study. J Neurooncol 115(1):87–94. https://doi.org/10.1007/s11060-013-1198-z CrossRefPubMed

40.

Boele FW, Douw L, Reijneveld JC, Robben R, Taphoorn MJ, Aaronson NK, Heimans JJ, Klein M (2015) Health-related quality of life in stable, long-term survivors of low-grade glioma. J Clin Oncol 33(9):1023–1029. https://doi.org/10.1200/JCO.2014.56.9079 CrossRefPubMed

41.

Boele FW, Rooney AG, Grant R, Klein M (2015) Psychiatric symptoms in glioma patients: from diagnosis to management. Neuropsychiatr Dis Treat 11:1413–1420. https://doi.org/10.2147/NDT.S65874 CrossRefPubMedPubMedCentral

42.

Boele FW, van Uden-Kraan CF, Hilverda K, Reijneveld JC, Cleijne W, Klein M, Verdonck-de Leeuw IM (2016) Attitudes and preferences toward monitoring symptoms, distress, and quality of life in glioma patients and their informal caregivers. Support Care Cancer 24(7):3011–3022. https://doi.org/10.1007/s00520-016-3112-7 CrossRefPubMedPubMedCentral

43.

Francis SR, Hall EOC, Delmar C (2019) Ethical dilemmas experienced by spouses of a partner with brain tumour. Nurs Ethics:1–11. https://doi.org/10.1177/0969733019857790

44.

Ownsworth T, Goadby E, Chambers SK (2015) Support after brain tumor means different things: family caregivers’ experiences of support and relationship changes. Front Oncol 5(33):1–13. https://doi.org/10.3389/fonc.2015.00033 CrossRef

45.

Costa DSJ, Fardell JE (2019) Why are objective and perceived cognitive function weakly correlated in patients with cancer? J Clin Oncol 37(14):1154–1158. https://doi.org/10.1200/JCO.18.02363 CrossRefPubMed

46.

Cull A, Hay C, Love SB et al (1996) What do cancer patients mean when they complain of concentration and memory problems? Br J Cancer 74(10):1674–1679. https://doi.org/10.1038/bjc.1996.608 CrossRefPubMedPubMedCentral

47.

Strober LB, Binder A, Nikelshpur OM et al (2016) The perceived deficits questionnaire: perception, deficit, or distress? Int J MS Care 18(4):183–190. https://doi.org/10.7224/1537-2073.2015-028 CrossRefPubMedPubMedCentral

48.

Pranckeviciene A, Deltuva VP, Tamasauskas A, Bunevicius A (2017) Association between psychological distress, subjective cognitive complaints and objective neuropsychological functioning in brain tumor patients. Clin Neurol Neurosurg 163:18–23. https://doi.org/10.1016/j.clineuro.2017.10.007 CrossRefPubMed

49.

Di Iulio F, Cravello L, Shofany J et al (2019) Neuropsychological disorders in non-central nervous system cancer: a review of objective cognitive impairment, depression, and related rehabilitation options. Neurol Sci 40(9):1759–1774. https://doi.org/10.1007/s10072-019-03898-0 CrossRefPubMed

50.

Gerstner ER, Batchelor TT (2010) Primary central nervous system lymphoma. Arch Neurol 67(3):291–297. https://doi.org/10.1001/archneurol.2010.3 CrossRefPubMed

51.

Juergens A, Pels H, Rogowski S et al (2010) Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma. Ann Neurol 67(2):182–189. https://doi.org/10.1002/ana.21824 CrossRefPubMed

52.

Korfel A, Schlegel U (2013) Diagnosis and treatment of primary CNS lymphoma. Nat Rev Neurol 9(6):317–327. https://doi.org/10.1038/nrneurol.2013.83 CrossRefPubMed

53.

Pels H, Schmidt-Wolf IGH, Glasmacher A, Schulz H, Engert A, Diehl V, Zellner A, Schackert G, Reichmann H, Kroschinsky F, Vogt-Schaden M, Egerer G, Bode U, Schaller C, Deckert M, Fimmers R, Helmstaedter C, Atasoy A, Klockgether T, Schlegel U (2003) Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol 21(24):4489–4495. https://doi.org/10.1200/JCO.2003.04.056 CrossRefPubMed

54.

Seidel S, Korfel A, Kowalski T, Margold M, Ismail F, Schroers R, Baraniskin A, Pels H, Martus P, Schlegel U (2019) HDMTX-based induction therapy followed by consolidation with conventional systemic chemotherapy and intraventricular therapy (modified Bonn protocol) in primary CNS lymphoma: a monocentric retrospective analysis. Neurological Research and Practice 1(17):1–9. https://doi.org/10.1186/s42466-019-0024-2 CrossRef

55.

Dallabona M, Sarubbo S, Merler S, Corsini F, Pulcrano G, Rozzanigo U, Barbareschi M, Chioffi F (2017) Impact of mass effect, tumor location, age, and surgery on the cognitive outcome of patients with high-grade gliomas: a longitudinal study. Neurooncol Pract 4(4):229–240. https://doi.org/10.1093/nop/npw030 CrossRefPubMedPubMedCentral

56.

Mandonnet E, de Witt Hamer PC, Poisson I et al (2015) Initial experience using awake surgery for glioma: oncological, functional, and employment outcomes in a consecutive series of 25 cases. Neurosurgery 76(4):382–389. https://doi.org/10.1227/NEU.0000000000000644 CrossRefPubMed

57.

Noll KR, Weinberg JS, Ziu M, Benveniste RJ, Suki D, Wefel JS (2015) Neurocognitive changes associated with surgical resection of left and right temporal lobe glioma. Neurosurgery 77(5):777–785. https://doi.org/10.1227/NEU.0000000000000987 CrossRefPubMed

58.

Satoer D, Visch-Brink E, Smits M, Kloet A, Looman C, Dirven C, Vincent A (2014) Long-term evaluation of cognition after glioma surgery in eloquent areas. J Neurooncol 116(1):153–160. https://doi.org/10.1007/s11060-013-1275-3 CrossRefPubMed

59.

Talacchi A, Santini B, Savazzi S, Gerosa M (2011) Cognitive effects of tumour and surgical treatment in glioma patients. J Neurooncol 103(3):541–549. https://doi.org/10.1007/s11060-010-0417-0 CrossRefPubMed

60.

Wu AS, Witgert ME, Lang FF, Xiao L, Bekele BN, Meyers CA, Ferson D, Wefel JS (2011) Neurocognitive function before and after surgery for insular gliomas. J Neurosurg 115(6):1115–1125. https://doi.org/10.3171/2011.8.JNS11488 CrossRefPubMed

61.

Bogdanova Y, Yee MK, Ho VT, Cicerone KD (2016) Computerized cognitive rehabilitation of attention and executive function in acquired brain injury: a systematic review. J Head Trauma Rehabil 31(6):419–433. https://doi.org/10.1097/HTR.0000000000000203 CrossRefPubMedPubMedCentral

62.

Amidei C (2018) Symptom-based interventions to promote quality survivorship. Neuro Oncol 20(suppl_7):27–39. https://doi.org/10.1093/neuonc/noy100 CrossRef

63.

Alaszewski A, Alaszewski H, Potter J, Penhale B (2007) Working after a stroke: survivors’ experiences and perceptions of barriers to and facilitators of the return to paid employment. Disabil Rehabil 29(24):1858–1869. https://doi.org/10.1080/09638280601143356 CrossRefPubMed

64.

Saunders SL, Nedelec B (2014) What work means to people with work disability: a scoping review. J Occup Rehabil 24(1):100–110. https://doi.org/10.1007/s10926-013-9436-y CrossRefPubMed

Titel: Research on cognitive and sociocognitive functions in patients with brain tumours: a bibliometric analysis and visualization of the scientific landscape
verfasst von: Milena Pertz
Stoyan Popkirov
Uwe Schlegel
Patrizia Thoma
Publikationsdatum: 12.02.2020
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 6/2020
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-020-04276-x

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Research on cognitive and sociocognitive functions in patients with brain tumours: a bibliometric analysis and visualization of the scientific landscape

Abstract

Background

Methods

Results

Conclusion

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2020

Neurology and the COVID-19 emergency

A survey on clinical pathways of patients with epilepsy and cerebrovascular diseases or brain tumors

Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM)

The minimal neuropsychological assessment of MS patients (MACFIMS): normative data of the Italian population

Italian translation and psychometric validation of the Manual Ability Measure-36 (MAM-36) and its correlation with an objective measure of upper limb function in patients with multiple sclerosis

Experiencing COVID19 pandemic and neurology: learning by the recent reports and by old literary or scientific descriptions

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie